Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

Italy's first Ebola patient treated with experimental drug

X
Your article was successfully shared with the contacts you provided.

(Bloomberg) — A doctor who has become the first Italian to contract Ebola arrived in Rome today and is being treated with an experimental antiviral drug.

His condition is ’’stable,’’ doctor Emanuele Nicastri said at a press conference at Rome’s Lazzaro Spallanzani hospital where the patient is being treated. ’’He’s conscious and collaborating’’ with the medical team.

The 50-year-old doctor, who contracted the virus in Sierra Leone while working for the charity Emergency, was flown to Pratica di Mare military airport near Rome and taken to the Lazzaro Spallanzani institute in a special ambulance, according to an e-mailed statement from the Italian air force. The patient’s family has asked that his name not be given to the press.

Rome doctors also declined to give the name of the antiviral drug used for treatment, though they said the drug has been used before in the U.S. and Europe.

More than 15,000 people have been infected with Ebola and 5,420 have died, according to the World Health Organization. Almost all have been concentrated in West Africa, including Liberia, Sierra Leone and Guinea.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.